These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33522821)

  • 1. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Case of Clofazimine and Poly(acrylic acid).
    Gui Y; McCann EC; Yao X; Li Y; Jones KJ; Yu L
    Mol Pharm; 2021 Mar; 18(3):1364-1372. PubMed ID: 33522821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Challenging Case of Lumefantrine-PAA.
    Yao X; Kim S; Gui Y; Chen Z; Yu J; Jones KJ; Yu L
    J Pharm Sci; 2021 Nov; 110(11):3670-3677. PubMed ID: 34371071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphous Drug-Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release.
    Neusaenger AL; Yao X; Yu J; Kim S; Hui HW; Huang L; Que C; Yu L
    Mol Pharm; 2023 Feb; 20(2):1347-1356. PubMed ID: 36668815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Stability and Dissolution of Amorphous Clofazimine by Polymer Nano-Coating.
    Gui Y; Chen Y; Chen Z; Jones KJ; Yu L
    Pharm Res; 2019 Mar; 36(5):67. PubMed ID: 30877389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
    Liu X; Zhou L; Zhang F
    Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of the Strength of Drug-Polymer Interactions on the Dissolution of Amorphous Solid Dispersions.
    Amponsah-Efah KK; Mistry P; Eisenhart R; Suryanarayanan R
    Mol Pharm; 2021 Jan; 18(1):174-186. PubMed ID: 33332132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Polymer Architecture and Acidic Group Density on the Degree of Salt Formation in Amorphous Solid Dispersions.
    Neusaenger AL; Fatina C; Yu J; Yu L
    Mol Pharm; 2024 Jul; 21(7):3375-3382. PubMed ID: 38885189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin.
    Li Y; Yu J; Hu S; Chen Z; Sacchetti M; Sun CC; Yu L
    Mol Pharm; 2019 Mar; 16(3):1305-1311. PubMed ID: 30668120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregated Solution Morphology of Poly(acrylic acid)-Poly(styrene) Block Copolymers Improves Drug Supersaturation Maintenance and Caco-2 Cell Membrane Permeation.
    Purchel AA; Boyle WS; Reineke TM
    Mol Pharm; 2019 Nov; 16(11):4423-4435. PubMed ID: 31633362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring supersaturation from amorphous solid dispersions.
    Li N; Taylor LS
    J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage.
    Weuts I; Kempen D; Verreck G; Peeters J; Brewster M; Blaton N; Van den Mooter G
    Eur J Pharm Sci; 2005; 25(4-5):387-93. PubMed ID: 15894472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Effect of the Preparation Method and Compression on the Physical Stability and Dissolution Behavior of Melt-Quenched Amorphous Celecoxib.
    Be Rziņš KR; Fraser-Miller SJ; Di R; Liu J; Peltonen L; Strachan CJ; Rades T; Gordon KC
    Mol Pharm; 2021 Mar; 18(3):1408-1418. PubMed ID: 33586988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.